Medlumics Funding: $73M Raised, Series E (2021)

Medlumics funding overview

Medlumics is based in Madrid, Spain. Medlumics has raised $73M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series E announced in January 2021. The round record for Medlumics runs through 2021; nothing later has been disclosed. Investors on record include Asabys Partners, VI Partners, CDTI Innvierte, Andera Partners, Caixa Capital Risc, Innogest Capital and 2 others. 8 distinct backers are named across the disclosed rounds.

Medlumics at a glance

Total raised: $73M
Latest round: Series E
Latest round date: January 2021
Headquarters: Madrid, Spain
Notable investors: Asabys Partners, VI Partners, CDTI Innvierte, Andera Partners, Caixa Capital Risc, Innogest Capital, Kurma Partners, Seroba Life Sciences

Frequently asked about Medlumics funding

How much has Medlumics raised?: Medlumics has raised $73M in total disclosed funding across the rounds on record.
Who has invested in Medlumics?: Asabys Partners, VI Partners, CDTI Innvierte, Andera Partners, Caixa Capital Risc, Innogest Capital are named among the investors backing Medlumics.
What was the latest Medlumics funding round?: The most recent disclosed round is a Series E, announced in January 2021.
Where is Medlumics based?: Medlumics is based in Madrid, Spain.
When did Medlumics last raise?: The last disclosed Medlumics round closed in January 2021 at Series E.

Every Medlumics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Madrid at a similar stage.

Medlumics Funding: $73M Raised, Series E (2021)

Medlumics funding overview

Medlumics at a glance

Frequently asked about Medlumics funding

Companies related to Medlumics (23)

Browse related funding lists (4)